PET PET
  • My Account
  • Subscribe
Become a Friend Donate
  • About Us
    • People
    • Press Office
    • Our History
  • Get Involved
    • Become a Friend of PET
    • Volunteer
    • Campaigns
    • Writing Scheme
    • Partnership and Sponsorship
    • Advertise with Us
  • Donate
    • Become a Friend of PET
  • BioNews
    • News
    • Comment
    • Reviews
    • Elsewhere
    • Topics
    • Glossary
    • Newsletters
  • Events
    • Upcoming Events
    • Previous Events
  • Engagement
    • Policy and Projects
      • Resources
    • Education
  • Jobs & Opportunities
  • Contact Us
  • About Us
    • People
    • Press Office
    • Our History
  • Get Involved
    • Become a Friend of PET
    • Volunteer
    • Campaigns
    • Writing Scheme
    • Partnership and Sponsorship
    • Advertise with Us
  • Donate
    • Become a Friend of PET
  • BioNews
    • News
    • Comment
    • Reviews
    • Elsewhere
    • Topics
    • Glossary
    • Newsletters
  • Events
    • Upcoming Events
    • Previous Events
  • Engagement
    • Policy and Projects
      • Resources
    • Education
  • Jobs & Opportunities
  • Contact Us
  • My Account
  • Subscribe
  • Privacy Statement
  • Advertising Policy
  • Thanks and Acknowledgements
PETBioNewsNewsNew genetic links to pancreatic cancer discovered

BioNews

New genetic links to pancreatic cancer discovered

Published 25 April 2017 posted in News and appears in BioNews 889

Author

Jamie Rickman

Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the output from a DNA sequencing machine.
CC BY 4.0
Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the sequencing output from an automated DNA sequencing machine.

Researchers have used whole-genome sequencing to uncover new mutations responsible for a rare type of pancreatic cancer...

Researchers have used whole-genome sequencing to uncover new mutations responsible for a rare type of pancreatic cancer.

Nearly all patients with pancreatic neuroendocrine tumours (PanNETs) studied had no family history of disease, but the scientists found a clear genetic predisposition. They were also able to link PanNETs to genes associated with other cancers.

'In the future, patients at risk of this rare pancreatic cancer could be identifiable through genetic screening,' said the study co-leader Dr Nicola Waddell, QIMR Berghofer, Australia. There is currently no reliable test for pancreatic cancer.

Pancreatic cancer affects 1 in 71 people. The Australian team studied 102 patients diagnosed with PanNETs, which account for five percent of pancreatic tumours. The symptoms of PanNETs can be difficult to detect and diagnosis is often in the late stages; mortality rates are 60 percent.

The researchers looked for genetic mutations in tumour cells and also in somatic cells of the body that reveal germline mutations, which are heritable. Previously it was thought only five percent of PanNET tumours were linked to heritable genes, but the researchers found that a surprisingly high proportion of the mutations (17 percent) were linked to germline mutations. Mutations were associated with genes involved in DNA repair, cell proliferation, cell survival and cell ageing; processes almost universally disrupted in cancer.

The researchers were also surprised to find PanNETs could be linked to gene mutations known to predispose individuals to other cancers.

Professor Sean Grimmond of the University of Melbourne, co-leader of the study, said: 'We found that the MUTYH and BRCA2 gene mutations, normally associated with colon and breast cancers, also appear to play an important role in PanNETs… This raises exciting possibilities for how we treat this disease in the future.'

PanNETS are highly unpredictable and determining the appropriate treatment is a challenge. The researchers say that exploring the 'genomic landscape' of PanNETs, could help clinicians decide on the best therapy for an individual, potentially saving patients from unnecessary, aggressive treatments. The findings could also be used to identify people at risk of these cancers.

The patients were recruited via the International Cancer Genome Consortium, and the Australian team collaborated with researchers from the US and Europe. Professor Andrew Biankin, director of translational research at the University of Glasgow and co-lead of the study, said: 'This study is a great example of International Team Science… We managed to overcome all the societal hurdles of data and material sharing to make significant findings in an uncommon cancer type that can be difficult to treat.'

The study was published in the journal Nature.

Related Articles

PET BioNews
News
17 September 2021 • 2 minutes read

Pancreatic organoids grown on synthetic structure give insight into cancer

by Semyon Bodian

Pancreatic organoids, grown using a newly developed gel, have enabled scientists to better understand pancreatic cancer...

Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the output from a DNA sequencing machine.
CC BY 4.0
Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the sequencing output from an automated DNA sequencing machine.
News
11 May 2018 • 2 minutes read

Genome editing could slow the growth of pancreatic cancer

by Shaoni Bhattacharya

Researchers have slowed the growth of pancreatic cancer by harnessing genome editing to remove key molecules implicated in its spread...

Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the output from a DNA sequencing machine.
CC BY 4.0
Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the sequencing output from an automated DNA sequencing machine.
News
30 March 2016 • 2 minutes read

Pancreatic cancer is 'four different diseases'

by Kulraj Singh Bhangra

A collaboration between scientists from around the world has identified four subtypes of pancreatic cancer...

Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the output from a DNA sequencing machine.
CC BY 4.0
Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the sequencing output from an automated DNA sequencing machine.
News
26 October 2012 • 2 minutes read

Genes for pancreatic cancer identified in international genome study

by Rivka Marks-Maran

Thousands of genetic mutations associated with pancreatic cancer have been identified in an international study...

PET BioNews
News
9 June 2009 • 2 minutes read

Familial pancreatic cancer gene identified

by Dr Jess Buxton

An international team of researchers has discovered that an altered version of a gene called Palladin causes an inherited form of pancreatic cancer. The findings, published online in the journal PloS Medicine, also reveal that the same gene is involved in sporadic cases of the disease...

Leave a Reply Cancel reply

You must be logged in to post a comment.

« Deaf mice able to hear 'whispers' after gene therapy

Data-Label The UK's Leading Supplier Of Medical Labels & Asset Labels

RetiringDentist.co.uk The UK's Leading M&A Company.

Find out how you can advertise here
easyfundraising
amazon

This month in BioNews

  • Popular
  • Recent
13 June 2022 • 2 minutes read

Drop in diversity of blood stem cells leads to old-age health issues

8 August 2022 • 2 minutes read

Placenta and organ formation observed in mouse embryo models

8 August 2022 • 2 minutes read

Complex structures of the human heart bioengineered

8 August 2022 • 1 minute read

Brain tumour gene also linked to childhood cancers

8 August 2022 • 2 minutes read

Lower hormone doses may improve IVF egg quality

8 August 2022 • 2 minutes read

Boosting muscle cell production of gene therapy proteins

Subscribe to BioNews and other PET updates for free.

Subscribe
  • Twitter
  • Facebook
  • Instagram
  • LinkedIn
  • YouTube
  • RSS
Wellcome
Website redevelopment supported by Wellcome.

Website by Impact Media Impact Media

  • Privacy Statement
  • Advertising Policy
  • Thanks and Acknowledgements

© 1992 - 2022 Progress Educational Trust. All rights reserved.

Limited company registered in England and Wales no 07405980 • Registered charity no 1139856

Subscribe to BioNews and other PET updates for free.

Subscribe
PET PET

PET is an independent charity that improves choices for people affected by infertility and genetic conditions.

  • Twitter
  • Facebook
  • Instagram
  • LinkedIn
  • YouTube
  • RSS
Wellcome
Website redevelopment supported by Wellcome.

Navigation

  • About Us
  • Get Involved
  • Donate
  • BioNews
  • Events
  • Engagement
  • Jobs & Opportunities
  • Contact Us

BioNews

  • News
  • Comment
  • Reviews
  • Elsewhere
  • Topics
  • Glossary
  • Newsletters

Other

  • My Account
  • Subscribe

Website by Impact Media Impact Media

  • Privacy Statement
  • Advertising Policy
  • Thanks and Acknowledgements

© 1992 - 2022 Progress Educational Trust. All rights reserved.

Limited company registered in England and Wales no 07405980 • Registered charity no 1139856